Minocycline to improve neurologic outcome in stroke (MINOS): a dose-finding study.

@article{Fagan2010MinocyclineTI,
  title={Minocycline to improve neurologic outcome in stroke (MINOS): a dose-finding study.},
  author={Susan C Fagan and Jennifer L Waller and Fenwick T. Nichols and D. A. Edwards and Luther Creed Pettigrew and Wayne M. Clark and Christiana E Hall and Jeffrey A. Switzer and Adviye Ergul and David C. Hess},
  journal={Stroke},
  year={2010},
  volume={41 10},
  pages={2283-7}
}
BACKGROUND AND PURPOSE Minocycline is a promising anti-inflammatory and protease inhibitor that is effective in multiple preclinical stroke models. We conducted an early phase trial of intravenous minocycline in acute ischemic stroke. METHODS Following an open-label, dose-escalation design, minocycline was administered intravenously within 6 hours of stroke symptom onset in preset dose tiers of 3, 4.5, 6, or 10 mg/kg daily over 72 hours. Minocycline concentrations for pharmacokinetic analysis… CONTINUE READING
Highly Influential
This paper has highly influenced 10 other papers. REVIEW HIGHLY INFLUENTIAL CITATIONS

Citations

Publications citing this paper.
Showing 1-10 of 83 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 26 references

: assessment of interaction potential

  • Y Murata, A Rosell, RH Scannevin, KJ Rhodes, X Wang, EH Lo
  • 2009

Extension of the thrombolytic window with minocycline in experimental

  • SC Fagan, DJ Edwards, +4 authors DC Hess
  • STROKE
  • 2008

MC inhibits poly (ADP ribose) polymerase I at nanomolar concentrations

  • CC Alano, TN Kauppinen, AV Vall, RA. Swanson
  • Proc Natl Acad Sci U S A 2006 June 12 [Epub ahead…
  • 2006
1 Excerpt

Similar Papers

Loading similar papers…